Tag Archives: WHO

Adiós! Goodbye, oncho! Mexico joins two other countries in ending onchocerciasis in LAC

Mission to verify the elimination of onchocerciasis in Ecuador. PAHO/WHO, 2014

Mission to verify the elimination of onchocerciasis in Ecuador. PAHO/WHO, 2014

I can’t wait to spread the news. The Latin American and the Caribbean (LAC) region is one step closer to seeing the end of onchocerciasis (also referred to as river blindness): Mexico has become the third country in the world to officially wipe out this disease!

The drive for progress is much of what motivated me during my time as the Director of the Pan American Health Organization, the WHO Regional Office for the Americas. I am excited to continue celebrating these milestones as Neglected Tropical Disease (NTD) Special Envoy, and a life-long advocate for public health.

Earlier this year, I wrote about 7 achievable victories in the fight against NTDs that I hope to see accomplished in 2015. Many of these wishes are coming true.

This week, I am filled with the joyful sense of pride in the accomplishment of Mexico and its partners as I check off Mexico’s certification of onchocerciasis elimination from my wish list. Mexico’s success builds off of Colombia and Ecuador’s certification in 2013 and 2014, respectively, and gives me even more confidence that we will soon see news of a LAC region completely free of onchocerciasis.

Onchocerciasis is a devastatingly debilitating parasitic disease that causes itchiness, rashes, and eye problems, eventually leading to permanent blindness. The parasite is transmitted to humans by the bite of a black fly, which breeds in fast moving rivers, increasing the risk of blindness in nearby communities. What’s more, the disease causes a terrible ripple effect by pulling kids out of school to care for their blind elders, reducing economic productivity, and causing families to move out of fertile river valleys, decreasing agricultural outputs in already impoverished areas.

This momentous occasion moves the LAC region one step closer to eliminating the disease entirely—Guatemala has already submitted a request to WHO to verify elimination, and I hope to soon see more results from the enormous, highly coordinated, south-south cooperative effort between Brazil and Venezuela to stop transmission in the Yanomami communities along their borders.

We should all celebrate this official announcement, and we must particularly congratulate Mexico and the many partners that have been working to control this problem for decades and moved toward accomplishing elimination with new tools and new partners for the last fifteen years. 

Eliminating this disease requires unwavering determination. The first step in the elimination process is at least two years of mass drug administration, in which entire communities who are at risk of onchocerciasis are administered Mectizan (ivermectin) every six months. Merck has made an unprecedented pledge to donate Mectizan to everyone in need, for as long as needed. President Jimmy Carter and the Carter´s Center program (OEPA – Onchocerciasis Elimination Program for the Americas) have been instrumental, joining PAHO/WHO as well as the communities and health workers in a successful dream team. You can see President Carter’s , congratulating partners for their hard-earned accomplishments.

Once large-scale programs are complete, treatments are delivered to individuals on an as-needed basis. Communities are monitored for an additional twelve years to make sure that transmission of this disease has been interrupted. Finally, after treatment and monitoring, countries stop the treatment intervention and watch for three years to ensure that there is no resurgence in transmission, and then apply for WHO certification that elimination has been achieved.

I was thrilled to be able to celebrate the long-term dedication and resulting accomplishment of all partners contributing to this milestone at an event at PAHO Headquarters last week. Health Ministers from the countries that have eliminated or will soon eliminate river blindness, technical advisors, and global policy leaders were specially recognized for the recent successes and spur motivation to run the race through the last mile all around the world. I was particularly moved when Dr. Etienne, Director of PAHO/WHO, when she received the award. The outstanding accomplishment of the countries in the Americas comes at an excellent time, now that NTDs are officially identified in the recently adopted Sustainable Development Goals. The LAC region has hit the ground running.

Dr. Mirta Roses Periago is the Director Emeritus of PAHO/WHO and a Special Envoy for the Global Network for Neglected Tropical Diseases

NTD Workshop in Nigeria Equips States with Necessary Skills and Resources to Succeed

 

Together with international partners and NGOs, the government of Nigeria has the potential to drastically expand and strengthen their neglected tropical disease (NTD) program to treat and protect its population from the devastating impact of NTDs. Nigeria bears the largest NTD burden within sub-Saharan Africa, but the country’s national plan to tackle NTDs has already laid the groundwork for controlling and eliminating these diseases by 2020. However, additional training, especially at the state level, will help Nigeria scale up and maintain a sustainable NTD program that could lead to the control and elimination of NTDs by 2020.

Nigeria’s geography poses a unique challenge in the fight against NTDs. For example, each Nigerian state possesses its own quasi-autonomous state ministry of health — each with its own integrated NTD program. With this challenge in mind, The World Health Organization (WHO) and partners developed a training program for the first week in February for the 36 Nigerian states and the Federal Capital Territory (FCT) to provide representatives with the tools and technical skills needed to establish, scale up and sustain integrated NTD programs within their respective states. The training was supported by The Envision project, The United project, and was attended by state representatives, including federal ministers of health, members of federal NTD teams and zonal coordinators and NGO partners.

Highlights from the 5-day training were shared through Twitter, thanks to and RTIinterntional:

 

Throughout the training, facilitators from Nigeria and the U.S. led sessions on scaling up integrated MDA programs, monitoring and evaluation, data management and advocacy. The facilitators also went over some basic but essential tasks – including filling out the appropriate forms to apply for NTD medications.

During her session, Global Network senior program officer Wangechi Thuo stressed the importance of effective advocacy in creating sustainable NTD programs. She led participants through exercises, demonstrating how to effectively raise awareness about NTDs among key policy influencers with the goal of garnering sustained ownership, leadership, and commitment from governments and their partners for NTD programs

 

The training also brought together key government partners including Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) and the National Primary Health Care Development Agency. Together, partners discussed ways to better and more effectively distribute NTD medicine to populations in need. While Nigeria has the medicine necessary to treat its population, delivering the medicine to more than a hundred million Nigerians is a difficult task.

As the globe moves towards NTD elimination by 2020, Nigeria must remain a top priority given its large NTD burden. Thanks to this month’s NTD workshop, Nigeria’s government expects to see more and more people treated for NTDs, and more precise monitoring and evaluation of drug delivery in the coming year. Through continued government and partner support, Nigeria can see the end of NTDs. In the words of Dr. Bridget Okuaguale, Director of Public Health (DPH) at the Federal Ministry of Health, “We must work as a team, or we cannot go anywhere.”

Calling All Collaborators to Eliminate Intestinal Worms in Children

 

Pictured from left to right: John A. Jufuor, President of the Republic of Ghana (2001-2009) and Global Network NTD Special Envoy; Bill Lin, director of Worldwide Corporate Contributions at Johnson & Johnson; Dr. Lorenzo Savioli, director of the Department of NTDs at WHO; Kathy Spahn, President and CEO of Helen Keller International (HKI); and Richard Besser, chief health and medical editor at ABC News

Pictured from left to right: John A. Kufuor, President of the Republic of Ghana (2001-2009) and Global Network NTD Special Envoy; Bill Lin, director of Worldwide Corporate Contributions at Johnson & Johnson; Dr. Lorenzo Savioli, director of the Department of NTDs at WHO; Kathy Spahn, President and CEO of Helen Keller International (HKI); and Dr. Richard Besser, chief health and medical editor at ABC News

“What we want to do is produce quality of life for the people.” – H.E. John A. Kufuor, President of the Republic of Ghana (2001-2009) and Global Network NTD Special Envoy

We have been anxiously awaiting the United Nations General Assembly’s (UNGA) sixty-eighth kick-off session, “The Post-2015 Development Agenda: Setting the Stage.” Neglected Tropical Diseases (NTDs) have impeded critical breakthroughs in development efforts for too long – plaguing one in six people globally, including half a billion children. While we have the medicine, which costs just 50 cents per person per year, we must garner greater attention, collaboration and political will to see the end of horrible suffering in the world’s most neglected communities.

We are certainly hopeful.

It was fitting that in the height of UNGA meetings, the Global Network, Johnson & Johnson, Children Without Worms, The Task Force for Global Health and the World Health Organization (WHO) co-hosted a conversation to identify innovative ways we can eliminate soil-transmitted helminth (STH) infections – one of the key diseases undercutting many Millennium Development Goals (MDGs).

“Business as usual” simply wouldn’t do! So, our event, “Innovate & Integrate: Multi-sectoral Approaches for Eliminating Intestinal Worms in Children,” set out to explore how and why organizations in the fields of NTDs; water, sanitation, and hygiene (WASH); nutrition; maternal and child health; and education can collaborate on this issue to ensure lasting advancements.

 

Bill Lin presents on NTDs and WASH

Bill Lin presents on NTDs and WASH

, director of Worldwide Corporate Contributions at Johnson & Johnson, opened with his experience growing up in a rural area outside of Hong Kong. Forever imprinted on him was the constant chanting of “wash your hands” and “don’t put your hands in your mouth.” “You [couldn’t] get clean water just by flipping a faucet.” Bill explained.

Bleak living conditions then and now have caused the perpetual transmission of intestinal worms. Therefore, we must not only distribute medicines to control STH infections but also work with partners to stop them from spreading. “There is a clear need for the education [and] health sectors to work together” to encourage behavioral changes.

, chief health and medical editor at ABC News then asked tough questions to our panelists: H.E. John A. Kufur, former president of the Republic of Ghana (2001-2009); Dr. Lorenzo Savioli, director of the Department of NTDs at WHO; and Ms. Kathy Spahn, President and CEO of Helen Keller International (HKI).

Recognizing that we were talking about “a disease that isn’t killing a lot of people” during a “busy week in New York,” Dr. Besser asked Dr. Savioli, “why does [STH] deserve attention?”

Optimistically, Dr. Lorenzo responded, “We can do something about it. We are eradicating guinea worm, we have the drugs to treat intestinal helminths … we can really interrupt transmission. We can make a difference with the tools we have in our hands.”

President Kufuor chimed in, “our goal is to seek solutions.” Speaking from his experiences in making NTD and WASH advancements as President of Ghana, including tremendous strides in the effort to eliminate guinea worm, President Kufuor noted that behavior change was critical, including “show[ing]  [people] how to boil water.” President Kufuor also stressed that the successes he oversaw were due to implementing policies that educated the public and provided infrastructure, and knowing when to “seek international help.”

Dr. Besser then asked Kathy, “Why does HKI think this is an important problem to tackle?”

Kathy answered that STH infections are “incredibly disabling” and threaten worker productivity, children’s attendance in school and the ability of children to achieve. We’re “really talking about the posterity of the country unless these diseases are tackled,” Kathy said.

Dr. Besser then asked President Kufuor about the widespread impact of intestinal worms. President Kufuor stated, “Worms prevent kids from getting full benefits. … The economy isn’t well when people have worms. … We tackle the problem from the source.”

President Kufuor also touched on a devastating consequence of STH infections: the impact on pregnant women and their babies: “Even with mothers, if they do not look after themselves well with what they eat, what they drink, then the fetus will not mature the way it should.”

Addressing the economic impact, Dr. Besser asked Dr. Savioli, “What evidence is there that these type of control efforts make a difference?” Dr. Savioli recognized that there is huge economic growth occurring in Africa, and that “those countries doing best in the African continent with NTDs are the ones that are doing better economically.”

Asking Kathy about whether it’s “idealistic to think that you can accomplish cross-sector integration,” Dr. Besser said, “Can it happen?” To which Kathy responded, “Nothing can happen unless you work cross-sectorally.”

Wrapping up the interviews, Dr. Besser asked, “If the MDGs don’t list NTDs, what does that mean?”

Dr. Savioli noted, “We need to put pressure to make sure that happens” and that, thanks to “a unique relationship between international organizations, NGOs, endemic states and the private sector,” we have a “historically unique” opportunity “in the history of public health.”

Kathy shared that we need to go beyond the drugs, giving the example of HKI’s partnership with Johnson & Johnson to develop curriculums in education – hand washing, face washing – in Cambodia to realize tremendous successes.

It’s no wonder that after the interviews and audience Q&A, Dr. Besser said, he has “about 50 more questions [he] would love to ask” and that we’re “fortunate to have such different perspectives on this problem.” STH is different in that the solution is known, and that “it’s a problem of will and resources to implement the solution,” Dr. Besser concluded.

In his closing remarks, Dr. Savioli stated, “We have the scientific evidence that when you treat people regularly, the morbidity goes down.” However, “countries have to be at the center of it” because “countries that have done well have performed better” in economic, health and other development markers.

“You deprive the country if you don’t do it,” Kathy closed.

Thanks to all for such an engaging, thought-provoking event! We look forward to seeing how cross-sectoral collaborationcan make a difference in STH control and elimination in children.

USAID Grants PAHO $5 Million to Improve Health in Latin America and the Caribbean

USAID has awarded the Pan American Health Organization (PAHO) an estimated $5,041,913 over the next three years to support PAHO and World Health Organization technical cooperation in global health activities within the Latin America and Caribbean region. The grant will support efforts to prevent and control diseases, such as onchocerciasis, as well as support activities that will help foster public health advancements. Read the excerpt below for more information, or visit the PAHO website to read the full press release.

The United States Agency for International Development (USAID) signed an agreement today with the Pan American Health Organization/World Health Organization (PAHO/WHO) that provides $5 million to improve health in Latin America and the Caribbean, with a focus on maternal and neonatal health and tuberculosis (TB).